Johnson & Johnson Biom X Inc. Call Options Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PHGE
# of Institutions
2Shares Held
301KCall Options Held
0Put Options Held
0About BiomX Inc.
- Ticker PHGE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,982,300
- Market Cap $16.8M
- Description
- BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...